Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
about
Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasmaalpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitorsFilamentous-actins in human hepatocarcinoma cells with CLSM.Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters.An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model.Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices.Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.Gene Transcriptional and Metabolic Profile Changes in Mimetic Aging Mice Induced by D-GalactoseProduction of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activityLysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts.Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.Roles of LPA in ovarian cancer development and progression.Autotaxin: its role in biology of melanoma cells and as a pharmacological target.Lysophosphatidic acid as a lipid mediator with multiple biological actions.Type 2 lysophosphatidic acid receptor in gastric surface mucous cells: Possible implication of prostaglandin E2 production.Salivary trefoil factor 3 enhances migration of oral keratinocytes.Saliva induces expression of antimicrobial peptides and promotes intracellular killing of bacteria in keratinocytes by epidermal growth factor receptor transactivation.Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves.Lysophosphatidic Acid signals through specific lysophosphatidic Acid receptor subtypes to control key regenerative responses of human gingival and periodontal ligament fibroblasts.Orally administered phosphatidic acids and lysophosphatidic acids ameliorate aspirin-induced stomach mucosal injury in mice.Lysophosphatidic acid modulates the regenerative responses of human gingival fibroblasts and enhances the actions of platelet-derived growth factor.A Major Human Oral Lysophosphatidic Acid Species, LPA 18:1, Regulates Novel Genes in Human Gingival Fibroblasts.Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.Biofunctionalized Lysophosphatidic Acid/Silk Fibroin Film for Cornea Endothelial Cell Regeneration.Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis
P2860
Q24300191-207B1080-28A4-483E-849B-9EF66CC7CCFDQ30435432-9025127B-C1E2-45A8-96B5-42DD4BA772F4Q31066279-3128532B-F94E-4473-B6CB-2B22E8313B50Q33206022-6A0C6173-DCFA-4437-B8D4-7BFD88F41900Q33825153-3048D6C9-652A-4E70-886B-690DFFDB3ADCQ33922964-B63F6E10-9022-49FD-9122-18C5EC093E13Q34774860-69036CD5-595E-4808-83F9-9E3987739CDAQ34944550-4DCE2515-D025-45CF-9184-1F3881B0C6E1Q34976113-AD2161BF-B8F5-48EB-A615-DDA6D0334B3BQ35098830-F5B80762-C868-4928-ADCC-4E8D4C2C9E20Q35691934-EEB0FDAB-705F-433B-BE47-A9EAC978E4B8Q35828519-FF455AA4-D659-424E-87C9-718B10D42168Q35951560-6EA3A10B-FCB0-4866-BCAB-DF6500DD5E18Q36907755-FBF2F093-C7DB-467E-813C-75E8601D557BQ37139302-71ACD3AE-F21E-43FD-AFFD-AC8C1F472EDAQ37433301-D85063E8-2461-467B-8F80-01C98777F0ACQ37650618-7FE8C694-5407-451B-AF21-1D44FC8D49DEQ37855574-D580CA75-C314-48CA-B79B-D9BA283E6402Q38286968-D70E2338-D806-4364-AB16-783333EDA2F3Q39038640-E052DF49-98EA-484C-8229-139507B4970AQ40000754-4DB6EF57-3B86-415C-9668-86923D65618BQ40601530-49A7FE84-197B-473B-B8D4-76B63EA540FDQ42798528-F55270DB-6415-47D0-BE46-C3FDD430B04AQ43298340-4A2CC345-E055-4A61-9598-A018552743CCQ44232180-655D3487-4353-4A9F-BB54-C8D6A69C9953Q44833041-6E9725F1-F2C9-46F8-B6D6-EF02934FA086Q46776126-0F0B81FA-9199-491F-A357-FA9FA39A15BEQ47191829-6BA4F11A-DD74-4908-8E80-BB6A9F50237CQ54961001-ED325F96-ACE5-4121-93E6-EB9562A885F0Q57067868-92946A34-FFCF-4FE1-BD5D-EDDAE155E127
P2860
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@ast
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@en
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@nl
type
label
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@ast
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@en
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@nl
prefLabel
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@ast
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@en
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@nl
P2093
P1476
Lysophosphatidic acid, a growth factor-like lipid, in the saliva.
@en
P2093
Akira Tokumura
Keizo Waku
Seishi Kishimoto
Shinji Nakane
Takayuki Sugiura
Yasuko Yoshioka
P304
P356
10.1194/JLR.M200242-JLR200
P577
2002-12-01T00:00:00Z